Asabys’ portfolio company Cara Care is acquired by Mahana Therapeutics to Become a Global Leader in the Digital Treatment of Digestive Disorders and other Chronic Conditions

by Asabys Partners

Mahana Therapeutics, a leading provider of digital chronic condition management programs, announced today that it has acquired Berlin-based HiDoc Technologies GmbH, operating as Cara Care, a leader in...

Read more

El Gobierno aprueba la creación de la primera sociedad mercantil de terapias avanzadas con capital público-privado de España con la participación del CDTI a través de Innvierte SICC

by CDTI

El Consejo de Ministros ha aprobado la creación de la primera sociedad mercantil de terapias avanzadas con capital público-privado de España, fruto de un pacto de socios que se formalizará entre e...

Read more

ICF invests €8M in life sciences through Invivo Ventures III fund

by Institut Català de Finances (ICF)

Taking advantage of a long history of collaboration, the Catalan Institute of Finance (ICF) once again invests in Invivo Partners. On this occasion, the public promotion bank of the Generalitat invest...

Read more

El CDTI Innovación invierte, junto con BIO & TECH SMART CAPITAL FCRE, en ONCOSTELLAE, que desarrolla fármacos para el tratamiento de enfermedades con necesidades médicas no cubiertas

by CDTI

El CDTI Innovación, a través de su programa Innvierte, conjuntamente con BIO & TECH SMART CAPITAL FCRE, ha alcanzado un acuerdo con los socios de ONCOSTELLAE, S.L., para entrar en el capital de la c...

Read more

Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies

by Ysios Capital

The round was co-led by new investors F-Prime Capital, Forbion, and Norwest Venture Partners, with participation from RiverVest Venture Partners, Red Tree Venture Capital, funds managed by abrdn Inc.,...

Read more

Cure51 capta 15 millones de euros en una ronda semilla para desarrollar tratamientos innovadores contra el cáncer

by Professional Newco

Cure51, empresa de biotecnología que investiga los mecanismos biológicos responsables de la supervivencia en pacientes con cáncer de alto riesgo, ha recaudado 15 millones de euros en una ronda de f...

Read more

Univo IRB has been added to the Qualitas Funds IV portfolio

by Qualitas Funds

Established in 2016, Univo IRB is an Independent Review Board (IRB) focused on serving biotech and small pharma sectors. The company specializes in the ethical review of Phase I-IV pharmaceutical, dev...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

tuTECHÔ se convierte en la primera empr...

by EY - Ernst & Young

tuTECHÔ, empresa social que lucha contra el sinhogarismo en España, ...

Photos Stream